Multidrug nanosuspensions: future perspectives on drug delivery system for HIV combination antiretroviral therapy

被引：0
作者：
Tartaglia, Alessandra [1 ]
机构：
[1] Univ Foggia, SC Malattie Infett, Dipartimento Med Clin & Sperimentale, Viale L Pinto 1, Foggia, Italy
来源：
AIDS | 2018年 / 32卷 / 17期
关键词：
long-acting HIV drugs; nanoformulations; NANOPARTICLES; OPPORTUNITIES; CABOTEGRAVIR; REPLICATION; INFECTION; RESERVOIR;
D O I：
10.1097/QAD.0000000000001971
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：2629 / 2631
页数：3
相关论文
共 15 条
  • [1] HIV reservoirs as obstacles and opportunities for an HIV cure
    Chun, Tae-Wook
    Moir, Susan
    Fauci, Anthony S.
    [J]. NATURE IMMUNOLOGY, 2015, 16 (06) : 584 - 589
  • [2] Development of HIV Reservoir Targeted Long Acting Nanoformulated Antiretroviral Therapies
    Edagwa, Benson J.
    Zhou, Tian
    McMillan, JoEllyn M.
    Liu, Xin-Ming
    Gendelman, Howard E.
    [J]. CURRENT MEDICINAL CHEMISTRY, 2014, 21 (36) : 4186 - 4198
  • [3] Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues
    Fletcher, Courtney V.
    Staskus, Kathryn
    Wietgrefe, Stephen W.
    Rothenberger, Meghan
    Reilly, Cavan
    Chipman, Jeffrey G.
    Beilman, Greg J.
    Khoruts, Alexander
    Thorkelson, Ann
    Schmidt, Thomas E.
    Anderson, Jodi
    Perkey, Katherine
    Stevenson, Mario
    Perelson, Alan S.
    Douek, Daniel C.
    Haase, Ashley T.
    Schacker, Timothy W.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (06) : 2307 - 2312
  • [4] Anti-HIV Drug-Combination Nanoparticles Enhance Plasma Drug Exposure Duration as Well as Triple-Drug Combination Levels in Cells Within Lymph Nodes and Blood in Primates
    Freeling, Jennifer P.
    Koehn, Josefin
    Shu, Cuiling
    Sun, Jianguo
    Ho, Rodney J. Y.
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2015, 31 (01) : 107 - 114
  • [5] Koehn J, 2018, AIDS, V32, P2463, DOI [10.1097/QAD.0000000000001969, 10.1097/qad.0000000000001969]
  • [6] Assessment of interactions of efavirenz solid drug nanoparticles with human immunological and haematological systems
    Liptrott, Neill J.
    Giardiello, Marco
    McDonald, Tom O.
    Rannard, Steve P.
    Owen, Andrew
    [J]. JOURNAL OF NANOBIOTECHNOLOGY, 2018, 16
  • [7] Persistent HIV-1 replication maintains the tissue reservoir during therapy
    Lorenzo-Redondo, Ramon
    Fryer, Helen R.
    Bedford, Trevor
    Kim, Eun-Young
    Archer, John
    Pond, Sergei L. Kosakovsky
    Chung, Yoon-Seok
    Penugonda, Sudhir
    Chipman, Jeffrey G.
    Fletcher, Courtney V.
    Schacker, Timothy W.
    Malim, Michael H.
    Rambaut, Andrew
    Haase, Ashley T.
    McLean, Angela R. .
    Wolinsky, Steven M.
    [J]. NATURE, 2016, 530 (7588) : 51 - +
  • [8] Cutaneous injection site reactions to long-term therapy with enfuvirtide
    Maggi, P
    Ladisa, N
    Cinori, E
    Altobella, A
    Pastore, G
    Filotico, R
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 53 (04) : 678 - 681
  • [9] Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial
    Margolis, David A.
    Gonzalez-Garcia, Juan
    Stellbrink, Hans-Juergen
    Eron, Joseph J.
    Yazdanpanah, Yazdan
    Podzamczer, Daniel
    Lutz, Thomas
    Angel, Jonathan B.
    Richmond, Gary J.
    Clotet, Bonaventura
    Gutierrez, Felix
    Sloan, Louis
    St Clair, Marty
    Murray, Miranda
    Ford, Susan L.
    Mrus, Joseph
    Patel, Parul
    Crauwels, Herta
    Griffith, Sandy K.
    Sutton, Kenneth C.
    Dorey, David
    Smith, Kimberly Y.
    Williams, Peter E.
    Spreen, William R.
    [J]. LANCET, 2017, 390 (10101) : 1499 - 1510
  • [10] Long-acting antiviral agents for HIV treatment
    Margolis, David A.
    Boffito, Marta
    [J]. CURRENT OPINION IN HIV AND AIDS, 2015, 10 (04) : 246 - 252
12